Is IUGNF or JEPQ a better dividend investment in 2026?

IUGNF currently yields 1788.91% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: IUGNF offers higher current income.

What is the dividend yield difference between IUGNF and JEPQ?

IUGNF has a forward dividend yield of 1788.91% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 1777.81 percentage points.

Home › Compare › IUGNF vs JEPQ

IUGNF vs JEPQ: Dividend Comparison 2026

IUGNF yields 1788.91% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IUGNF wins by $3531675981.96M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IUGNF

● Live price

1788.91%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3531675982.01M

Annual income

$3,181,793,952,650,469.00

Full IUGNF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — IUGNF vs JEPQ

📍 IUGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IUGNF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IUGNF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IUGNF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IUGNF

Annual income on $10K today (after 15% tax)

$152,057.25/yr

After 10yr DRIP, annual income (after tax)

$2,704,524,859,752,898.50/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, IUGNF beats the other by $2,704,524,859,751,069.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IUGNF + JEPQ for your $10,000?

IUGNF: 50%JEPQ: 50%

100% JEPQ50/50100% IUGNF

Portfolio after 10yr

$1765837991.03M

Annual income

$1,590,896,976,326,310.80/yr

Blended yield

90.09%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IUGNF buys

JEPQ buys

No recent congressional trades found for IUGNF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIUGNFJEPQ

Forward yield	1788.91% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3531675982.01M ✓	$44.8K
Annual income after 10y	$3,181,793,952,650,469.00 ✓	$2,152.59
Total dividends collected	$3506616114.25M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: IUGNF vs JEPQ ($10,000, DRIP)

Year	IUGNF Portfolio	IUGNF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$189,591	$178,890.88	$11,930	$1,110.39	+$177.7K → IUGNF
2	$3,372,589	$3,169,726.93	$14,133	$1,224.34	+$3.36M → IUGNF
3	$56,305,450	$52,696,779.78	$16,632	$1,340.46	+$56.29M → IUGNF
4	$882,465,426	$822,218,594.62	$19,454	$1,457.97	+$882.45M → IUGNF
5	$12,987,684,313	$12,043,446,306.47	$22,626	$1,576.08	+$12987.66M → IUGNF
6	$179,550,479,073	$165,653,656,858.63	$26,175	$1,694.09	+$179550.45M → IUGNF
7	$2,332,406,409,977	$2,140,287,397,368.80	$30,133	$1,811.32	+$2332406.38M → IUGNF
8	$28,479,672,886,997	$25,983,998,028,321.59	$34,531	$1,927.17	+$28479672.85M → IUGNF
9	$326,992,550,798,860	$296,519,300,809,773.56	$39,403	$2,041.08	+$326992550.76M → IUGNF
10	$3,531,675,982,005,250	$3,181,793,952,650,469.00	$44,787	$2,152.59	+$3531675981.96M → IUGNF

IUGNF vs JEPQ: Complete Analysis 2026

IUGNF — Stock

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research collaboration with Celularity Inc. to develop the combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19 for the treatment of solid tumors; and has a strategic collaboration with Eureka Therapeutics, Inc. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.

Full IUGNF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this IUGNF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IUGNF vs SCHD IUGNF vs JEPI IUGNF vs O IUGNF vs KO IUGNF vs MAIN IUGNF vs XYLD IUGNF vs QYLD IUGNF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.